Crossmark

Assessment of the Anti-Breast Cancer Effects of Urolithin with Molecular Docking Studies in the In Vitro Condition: Introducing a Novel Chemotherapeutic Drug

Crossref DOI link: https://doi.org/10.1007/s12033-023-00766-3

Published Online: 2023-06-06

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Lu

Zhao, Danbo https://orcid.org/0000-0003-1973-4461
Li, Ya

Jin, Jianwei

El-kott, Attalla F.

Al-Saeed, Fatimah A.

Eldib, Ali M.
License Information

Text and Data Mining valid from 2023-06-06

Version of Record valid from 2023-06-06
More Information

Article History

Received: 14 January 2023

Accepted: 4 May 2023

First Online: 6 June 2023

Declarations

:

: The authors declare that there are no conflicts of interest.

Document is current

Any future updates will be listed below